These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 12884985

  • 1. Multicentre evaluation of in vitro contracture testing with bolus administration of 4-chloro-m-cresol for diagnosis of malignant hyperthermia susceptibility.
    Wappler F, Anetseder M, Baur CP, Censier K, Doetsch S, Felleiter P, Fiege M, Fricker R, Halsall PJ, Hartung E, Heffron JJ, Heytens L, Hopkins PM, Klingler W, Lehmann-Horn F, Nivoche Y, Tegazzin V, Tzanova I, Urwyler A, Weisshorn R, Schulte am Esch J.
    Eur J Anaesthesiol; 2003 Jul; 20(7):528-36. PubMed ID: 12884985
    [Abstract] [Full Text] [Related]

  • 2. A multicenter study of 4-chloro-m-cresol for diagnosing malignant hyperthermia susceptibility.
    Baur CP, Bellon L, Felleiter P, Fiege M, Fricker R, Glahn K, Heffron JJ, Herrmann-Frank A, Jurkat-Rott K, Klingler W, Lehane M, Ording H, Tegazzin V, Wappler F, Georgieff M, Lehmann-Horn F.
    Anesth Analg; 2000 Jan; 90(1):200-5. PubMed ID: 10625004
    [Abstract] [Full Text] [Related]

  • 3. Classification of malignant hyperthermia-equivocal patients by 4-chloro-M-cresol.
    Gilly H, Musat I, Fricker R, Bittner RE, Steinbereithner K, Kress HG.
    Anesth Analg; 1997 Jul; 85(1):149-54. PubMed ID: 9212139
    [Abstract] [Full Text] [Related]

  • 4. 4-Chloro-m-cresol test--a possible supplementary test for diagnosis of malignant hyperthermia susceptibility.
    Ording H, Glahn K, Gardi T, Fagerlund T, Bendixen D.
    Acta Anaesthesiol Scand; 1997 Sep; 41(8):967-72. PubMed ID: 9311392
    [Abstract] [Full Text] [Related]

  • 5. [4-chloro-m-cresol-induced contractures of skeletal muscle specimen from patients at risk for malignant hyperthermia].
    Wappler F, Scholz J, von Richthofen V, Fiege M, Steinfath M, Schulte am Esch J.
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1997 Sep; 32(9):541-8. PubMed ID: 9417254
    [Abstract] [Full Text] [Related]

  • 6. 4-chloro-m-cresol triggers malignant hyperthermia in susceptible swine at doses greatly exceeding those found in drug preparations.
    Iaizzo PA, Johnson BA, Nagao K, Gallagher WJ.
    Anesthesiology; 1999 Jun; 90(6):1723-32. PubMed ID: 10360872
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the segregation of the RYR1 C1840T mutation with segregation of the caffeine/halothane contracture test results for malignant hyperthermia susceptibility in a large Manitoba Mennonite family.
    Serfas KD, Bose D, Patel L, Wrogemann K, Phillips MS, MacLennan DH, Greenberg CR.
    Anesthesiology; 1996 Feb; 84(2):322-9. PubMed ID: 8602662
    [Abstract] [Full Text] [Related]

  • 8. 5-HT2 receptor antagonist-mediated inhibition of halothane-induced contractures in skeletal muscle specimens from malignant hyperthermia susceptible patients.
    Wappler F, Scholz J, Fiege M, Richter A, Steinfath M, Weisshorn R, Schulte am Esch J.
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Oct; 360(4):376-81. PubMed ID: 10551274
    [Abstract] [Full Text] [Related]

  • 9. Sources of variability in halothane and caffeine contracture tests for susceptibility to malignant hyperthermia.
    Ording H, Bendixen D.
    Eur J Anaesthesiol; 1992 Sep; 9(5):367-76. PubMed ID: 1396623
    [Abstract] [Full Text] [Related]

  • 10. In vitro effects of 4-chloro-3-ethylphenol in skeletal muscle preparations from malignant hyperthermia susceptible and normal swine.
    Gerbershagen MU, Wappler F, Fiege M, Weilsshorn R, Alberts PA, von Breunig F, Schulte am Esch J.
    Eur J Anaesthesiol; 2002 Feb; 19(2):135-40. PubMed ID: 11999597
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Malignant hyperthermia (MH) diagnostics: a comparison between the halothane-caffeine- and the ryanodine-contracture-test results in MH susceptible, normal and control muscle.
    Hartung E, Koob M, Anetseder M, Schoemig P, Krauspe R, Hogrefe G, Engelhardt W.
    Acta Anaesthesiol Scand; 1996 Apr; 40(4):437-44. PubMed ID: 8738688
    [Abstract] [Full Text] [Related]

  • 13. Effect of cocaine on the contracture response to 1% halothane in patients undergoing diagnostic muscle biopsy for malignant hyperthermia.
    Sato N, Brum JM, Mitsumoto H, DeBoer GE.
    Can J Anaesth; 1995 Feb; 42(2):158-62. PubMed ID: 7720160
    [Abstract] [Full Text] [Related]

  • 14. Sevoflurane is less sensitive than halothane for in vitro detection of malignant hyperthermia susceptibility.
    Johannsen S, Klingler W, Schneiderbanger D, Heiderich S, Roewer N, Schuster F.
    Acta Anaesthesiol Scand; 2013 Oct; 57(9):1161-6. PubMed ID: 23957432
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects of the phosphodiesterase-III inhibitor enoximone on skeletal muscle specimens from malignant hyperthermia susceptible patients.
    Fiege M, Wappler F, Scholz J, Weisshorn R, von Richthofen V, Schulte am Esch J.
    J Clin Anesth; 2000 Mar; 12(2):123-8. PubMed ID: 10818326
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.